Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.

Eli Lilly will acquire the AbbVie-backed neurological disease therapy developer in a $135m transaction that could top $1.2bn with milestone payments.

AMS, a developer of energy value assessment software, had raised $52m from investors including Engie, AGL Energy, Southern Company and GE Ventures.

Cuna Mutual's CMFG subsidiary had led digital lending software provider CuneXus' series A round three years ago.

SoftBank has exited the electronic health record platform through a $32.7m acquisition by medical school operator Afya.

Tencent and Comcast are also set to exit the African payment tool provider in a purchase by fellow investor Stripe reportedly sized at more than $200m.

Recruit Strategic Partners has exited the identity management platform developer in a purchase by Ping Identity.

GV is set to exit customer data management platform Segment in an all-share deal that more than doubles its valuation from 18 months ago.

Z Corporation has exited its 40% stake in crypto trading exchange TaoTao in an acquisition by SBI.

Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.